These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19441164)

  • 21. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
    Marini A; Mirmohammadsadegh A; Nambiar S; Gustrau A; Ruzicka T; Hengge UR
    J Invest Dermatol; 2006 Feb; 126(2):422-31. PubMed ID: 16374457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.
    Helmbold P; Richter AM; Walesch S; Skorokhod A; Marsch WCh; Enk A; Dammann RH
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):687-94. PubMed ID: 22113481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis.
    De Araújo ÉS; Kashiwabara AY; Achatz MI; Moredo LF; De Sá BC; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
    Melanoma Res; 2015 Apr; 25(2):173-7. PubMed ID: 25647737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic hierarchy within the MAGEA1 cancer-germline gene: promoter DNA methylation dictates local histone modifications.
    Cannuyer J; Loriot A; Parvizi GK; De Smet C
    PLoS One; 2013; 8(3):e58743. PubMed ID: 23472218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
    J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation.
    Kaneda A; Tsukamoto T; Takamura-Enya T; Watanabe N; Kaminishi M; Sugimura T; Tatematsu M; Ushijima T
    Cancer Sci; 2004 Jan; 95(1):58-64. PubMed ID: 14720328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CpG island methylation profiling in human salivary gland adenoid cystic carcinoma.
    Bell A; Bell D; Weber RS; El-Naggar AK
    Cancer; 2011 Jul; 117(13):2898-909. PubMed ID: 21692051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.
    de Araújo ÉS; Pramio DT; Kashiwabara AY; Pennacchi PC; Maria-Engler SS; Achatz MI; Campos AH; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
    Biomed Res Int; 2015; 2015():376423. PubMed ID: 26106605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma.
    Falzone L; Salemi R; Travali S; Scalisi A; McCubrey JA; Candido S; Libra M
    Aging (Albany NY); 2016 May; 8(5):933-44. PubMed ID: 27115178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
    Jonsson A; Tuominen R; Grafström E; Hansson J; Egyhazi S
    J Invest Dermatol; 2010 Dec; 130(12):2809-17. PubMed ID: 20703244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation of CpG island promoters in uveal melanoma.
    Moulin AP; Clément G; Bosman FT; Zografos L; Benhattar J
    Br J Ophthalmol; 2008 Feb; 92(2):281-5. PubMed ID: 18211945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
    Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y
    Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.
    Cohen Y; Merhavi-Shoham E; Avraham RB; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Exp Eye Res; 2008 Feb; 86(2):201-6. PubMed ID: 18068703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.
    Imura M; Yamashita S; Cai LY; Furuta J; Wakabayashi M; Yasugi T; Ushijima T
    Cancer Lett; 2006 Sep; 241(2):213-20. PubMed ID: 16303245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.